Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "Sourcing"

115 News Found

TÜV SÜD inaugurates € 15 million Laboratory & Training Centre Bengaluru Campus
News | December 17, 2023

TÜV SÜD inaugurates € 15 million Laboratory & Training Centre Bengaluru Campus

Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services


Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations
Sustainability | December 04, 2023

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative


Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
News | October 17, 2023

Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site

Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening


Zydus appoints Punit Patel as President and CEO, Americas
People | October 16, 2023

Zydus appoints Punit Patel as President and CEO, Americas

Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace


M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData
News | July 20, 2023

M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData

CMOs showed an increasing reluctance to take on debt in 2022


Syngene to acquire multi-modal facility from Stelis Biopharma
News | July 05, 2023

Syngene to acquire multi-modal facility from Stelis Biopharma

Adding 20,000 liters of installed biologics drug substance manufacturing capacity


Adare Pharma divests Adare Biome to dsm-firmenich
News | July 04, 2023

Adare Pharma divests Adare Biome to dsm-firmenich

The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x


Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
interviews | June 20, 2023

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth


G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics
News | April 17, 2023

G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics

The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics


Getinge to boost scalability and deepen healthcare access in India
Medical Device | April 01, 2023

Getinge to boost scalability and deepen healthcare access in India

Getinge has a strong market share in India within several product segments